Last reviewed · How we verify

NCT05714410: TYPHOON-02

Evaluation of Changes in Bowel Movement Frequency Following the Consumption of PHGG Compared to Placebo

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing PHGG in Constipation - Functional in 160 participants. Completed in 19 January 2024.

Timeline
25 January 2023
Primary endpoint
19 January 2024
19 January 2024

Quick facts

Lead sponsorSociété des Produits Nestlé (SPN)
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeother
Enrollment160
Start date25 January 2023
Primary completion19 January 2024
Estimated completion19 January 2024
Sites1 location across Ireland

Drugs / interventions tested

Conditions studied

Sponsor

Société des Produits Nestlé (SPN) — full company profile →

Who can join

Adults 18 to 75, any sex, with Constipation - Functional. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of Changes in Bowel Movement Frequency Following the Consumption of Partially Hydrolyzed Guar Gum (PHGG) in Adults With Constipation as Compared to Placebo (Typhoon 2)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of PHGG

Trials testing the same drug.

Other recruiting trials for Constipation - Functional

Currently open trials in the same condition.

Other Société des Produits Nestlé (SPN) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05714410.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing